Literature DB >> 26209891

Evaluation and Differential Diagnosis of Persistent Marked Eosinophilia.

Casey Curtis1, Princess U Ogbogu2.   

Abstract

Peripheral blood eosinophilia is commonly encountered in clinical practice. The causes of peripheral blood eosinophilia are varied, ranging from benign eosinophilia to malignancy. A careful history and physical examination along with directed clinical evaluation may help determine the cause. When uncontrolled, peripheral blood eosinophilia may result in end-organ damage and life-threatening complications. This article summarizes the differential diagnosis and evaluation of persistent marked eosinophilia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eosinophilia; FIP1L1-PDGFRA; Hypereosinophilic syndrome; Lymphocytic hypereosinophilic syndrome (L-HES); Myeloproliferative hypereosinophilic syndrome (M-HES)

Mesh:

Substances:

Year:  2015        PMID: 26209891     DOI: 10.1016/j.iac.2015.04.001

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  10 in total

1.  Persistent eosinophilia in rheumatoid arthritis: a prospective observational study.

Authors:  Dantis Emmanuel; Subhash Chandra Parija; Ankit Jain; Durga Prasanna Misra; Rakhee Kar; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2018-11-13       Impact factor: 2.631

Review 2.  Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential.

Authors:  Francesco Menzella; Mirco Lusuardi; Carla Galeone; Sofia Taddei; Nicola Facciolongo; Luigi Zucchi
Journal:  Ther Adv Chronic Dis       Date:  2016-08-11       Impact factor: 5.091

Review 3.  Primary immunodeficiencies associated with eosinophilia.

Authors:  Behdad Navabi; Julia Elizabeth Mainwaring Upton
Journal:  Allergy Asthma Clin Immunol       Date:  2016-05-24       Impact factor: 3.406

4.  Peripheral eosinophilia in children with transient synovitis of the hip: 7-year experience from a single centre in New Zealand.

Authors:  Yassar Alamri; Allen Cockfield
Journal:  J Child Orthop       Date:  2016-04-15       Impact factor: 1.548

5.  Rapid Change in Mental Status in a Patient with Hypereosinophilia.

Authors:  Hanyin Wang; John K Erban
Journal:  Case Rep Hematol       Date:  2017-01-10

Review 6.  An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients.

Authors:  Justin T Schwartz; Patricia C Fulkerson
Journal:  Front Immunol       Date:  2018-09-03       Impact factor: 7.561

7.  Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients.

Authors:  Kittrawee Kritmetapak; Sirirat Anutrakulchai; Chatlert Pongchaiyakul; Anucha Puapairoj
Journal:  Clin Kidney J       Date:  2017-09-18

8.  Recurrent severe neutropenia following doxycycline use in a young healthy woman.

Authors:  Michael Foti; Tushaar V Shrimanker; Umar N Hasan; Khalil I Hussein
Journal:  Clin Case Rep       Date:  2022-03-01

9.  Parasitic Hypereosinophilia in Childhood: a Diagnostic Challenge.

Authors:  Roberto Antonucci; Nadia Vacca; Giulia Boz; Cristian Locci; Rosanna Mannazzu; Claudio Cherchi; Giacomo Lai; Claudio Fozza
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

Review 10.  The clinical profile of benralizumab in the management of severe eosinophilic asthma.

Authors:  Francesco Menzella; Mirco Lusuardi; Carla Galeone; Nicola Facciolongo; Luigi Zucchi
Journal:  Ther Adv Respir Dis       Date:  2016-09-09       Impact factor: 4.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.